Sanuwave Health (NASDAQ:SNWV) Rating Increased to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Sanuwave Health (NASDAQ:SNWV) from a hold rating to a buy rating in a research report released on Friday.

Several other equities research analysts have also recently issued reports on the stock. Northland Securities began coverage on shares of Sanuwave Health in a research report on Wednesday, September 3rd. They set an “outperform” rating and a $55.00 price objective for the company. Northland Capmk upgraded shares of Sanuwave Health to a “strong-buy” rating in a research report on Wednesday, September 3rd. Weiss Ratings restated a “sell (d-)” rating on shares of Sanuwave Health in a research report on Saturday, September 27th. Finally, Roth Capital raised their price objective on shares of Sanuwave Health from $54.00 to $55.00 and gave the stock a “buy” rating in a research report on Friday, August 22nd. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Sanuwave Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $55.00.

Sanuwave Health Stock Up 2.4%

Shares of NASDAQ SNWV opened at $37.43 on Friday. The firm has a 50-day simple moving average of $37.73 and a 200-day simple moving average of $33.87. The stock has a market capitalization of $320.78 million, a price-to-earnings ratio of -4.54 and a beta of 1.33. Sanuwave Health has a 52 week low of $5.63 and a 52 week high of $46.58.

Sanuwave Health (NASDAQ:SNWV) last issued its earnings results on Friday, August 8th. The company reported $0.01 EPS for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.10. The business had revenue of $10.16 million during the quarter, compared to analyst estimates of $10.14 million. Sanuwave Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in SNWV. Solas Capital Management LLC purchased a new position in shares of Sanuwave Health in the first quarter valued at approximately $20,658,000. AWM Investment Company Inc. purchased a new position in shares of Sanuwave Health in the first quarter valued at approximately $18,153,000. Geode Capital Management LLC purchased a new position in shares of Sanuwave Health in the second quarter valued at approximately $5,184,000. Stonebridge Wealth Management LLC purchased a new position in shares of Sanuwave Health in the second quarter valued at approximately $1,696,000. Finally, Evernest Financial Advisors LLC purchased a new position in shares of Sanuwave Health in the second quarter valued at approximately $823,000. Hedge funds and other institutional investors own 42.53% of the company’s stock.

About Sanuwave Health

SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.